Candesartan CAS 139481-59-7 Bohloeki >99.0% (HPLC) Factory
Ruifu Chemical Supply Candesartan Cilexetil Intermediate Ka Bohloeki bo Phahameng
Candesartan Cilexetil CAS 145040-37-5
Candesartan CAS 139481-59-7
1-Chloroethyl Cyclohexyl Carbonate CAS 99464-83-2
Candesartan Cilexetil Ea Hare Eethyl Ester C6 CAS 139481-41-7
Candesartan Cilexetil Intermediate CAS 139481-44-0
Trityl Candesartan Cilexetil CAS 170791-09-0
Lebitso la Lik'hemik'hale | Candesartan |
Litlhaloso tse tšoanang | CV-11974;2-Ethoxy-1-[[2'- (1H-tetrazol-5-yl) [1,1'-biphenyl] -4-yl]methyl] -1H-Benzimidazole-7-Carboxylic Acid;3- [[2'- (1H-Tetrazol-5-yl) biphenyl-4-yl]methyl]-2-ethoxy-3H-Benzimidazole-4-Carboxylic Acid;Candesartan M1;Candesartan Cilexetil EP Impurity G |
Nomoro ea CAS | 139481-59-7 |
Nomoro ea KAtse | RF-PI1889 |
Boemo ba Setoko | Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane |
Foromo ea limolek'hule | Setšoantšo sa C24H20N6O3 |
Boima ba Molek'hule | 440.45 |
Brand | Ruifu Chemical |
Ntho | Litlhaloso |
Ponahalo | Phofo e Tshweu |
Identification-HPLC | Nako ea ho Boloka e Tšoanang le Standard |
Boitsebiso-IR | E ts'oanang le Standard |
Mokhoa oa Bohloeki / Analysis | >99.0% (HPLC) |
Melting Point | 183.0 ~ 185.0 ℃ |
Tahlehelo ka ho Omisa | <0.50% |
Mongobo (KF) | <0.50% |
Masalla a ho Ignition | <0.50% |
Litšepe tse boima | <20ppm |
Tšilafalo ea Motho ka Mong | <1.00% (HPLC) |
Litšila ka Kakaretso | <1.00% (HPLC) |
Refractive Index | n20/D 1.745~1.747 |
Tekanyetso ea Teko | Maemo a Khoebo |
Tšebeliso | API;Bakeng sa Phekolo ea Khatello ea mali |
Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo
Candesartan (CAS: 139481-59-7) ke mohanyetsi oa angiotensin II receptor le IC50 ea 0.26 nM.Sepheo: Angiotensin II Receptor candesartan e bontšoa bakeng sa kalafo ea khatello ea mali.Candesartan Cilexetil e ile ea amoheloa ka lekhetlo la pele ka GB ka la 29 Apr, 1997, eaba ea amoheloa ke US Food and Drug Administration (FDA) ka June 4, 1998, 'me ea amoheloa ke Pharmaceuticals and Medical Devices Agency of Japan (PMDA) ka Mar 12, 1999. E hlahisitsoe ke AstraZeneca, ea ntan'o rekisoa e le Atacand ke AstraZeneca ka GB le US, 'me ea rekisoa e le Blopress ke Takeda ho JP.Candesartan Cilexetil ke angiotensin II receptor blocker (ARB), e thibela vasoconstrictor le litlamorao tsa aldosterone-secreting ea angiotensin II ka ho thibela ka boikhethelo tlamo ea angiotensin II ho receptor ea AT1 liseleng tse ngata, joalo ka mesifa e boreleli ea methapo le tšoelesa ea adrenal.Atacand e bontšoa bakeng sa phekolo ea khatello ea mali ho batho ba baholo le bana ba lilemo tse 1 ho isa ho tse <17, ho hloleha ha pelo (NYHA sehlopha sa II-IV) le ho sebelisoa ho fokotsa lefu la pelo le lefu la pelo le ho kena sepetlele.